COVID-19
A study out of China in 150 hospitalized patients conducted at 16 sites showed the medication did not help patients clear the virus better than standard care. It was also significantly more likely to cause serious side effects.
Sir Andrew Witty, the former head of GlaxoSmithKline, current president of UnitedHealth Group and chief executive officer of Optum, is temporarily stepping away from his duties to co-lead a World Health Organization effort to combat COVID-19.
Gilead said that the Phase III trial for mild to moderate patients had been ended because of lack of patients to enroll.
Social distancing has become the new norm in the attempt to prevent the spread of COVID-19, and that norm could become a mainstay of life for the next couple years, a new study suggests.
Antibody tests, also called serological tests, test if the individual has been exposed to SARS-CoV-2, the novel coronavirus that causes COVID-19.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 15, 2020.
A recent research article from Monash University in Australia showed that in a laboratory setting, the use of ivermectin, a decades-old drug approved to treat head lice infections as well as the treatment of some parasitic worms, inhibited the SARS-CoV-2 within 24 to 48 hours of treatment.
Origin, a 3D printing specialist for medical devices, just completed clinical trials and validation of its 3D-printed nasopharyngeal swabs for use in COVID-19 test kits. It is scaling up production and accepting orders to manufacture millions of the swabs.
It’s likely that more companies and universities will add additional assets as time goes on.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 14, 2020.
PRESS RELEASES